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Abstract
Endobronchial metastases (EBM) secondary to extrathoracic malignancies are very rare. Breast cancer, colorectal cancer and 
renal cell carcinoma represent the most common types of cancer leading to endobronchial metastases. They usually represent 
a late manifestation of other types of cancer and their prognosis is generally poor averaging a survival of 1-2 years in most case 
series. Due to their rarity, they remain a challenge for clinicians regarding whether they are primary lung tumors or not. This case 
report article intends to present a case of a young man with a left nephrectomy due to Clear-Cell Renal Cell Carcinoma, who de-
veloped EBM 7 years later and to summarize available data in the field. Furthermore, the utility of diathermic snare as a treatment 
approach for this entity is highlighted.
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Introduction
Endobronchial metastases (EBM) from 
extrathoracic malignancies are very rare [1]. 
Among those solid tumors occurring as EBM, 
breast, colorectal and renal cell represent the most 
common carcinomas [1–6]. Metastases arising 
from prostate, uterus, nasopharynx, as well mel-
anomas and sarcomas are less common [5]. EBM 
usually represent a  late manifestation of other 
types of cancer and their prognosis is generally 
poor. We herein present a case of a young man 
with a left nephrectomy due to Clear-Cell Renal 
Cell Carcinoma, who developed EBM 7 years later 
associated with recurrent episodes of pneumonia. 
Furthermore, the utility of diathermic snare as 
a treatment approach for this entity is highlighted.
Case report
A  47-year-old man, current smoker with 
a smoking history of 30 pack-years, presented to 
our interventional bronchoscopy unit to perform 
a bronchoscopy due to two episodes of recur-
rent pulmonary infections during the last year. 
According to his medical history, he had un-
dergone left nephrectomy for renal cell carci-
noma 7 years ago without adjuvant treatment. 
He had been clinically stable for 7 years until 
the investigation of cough with blood-streamed 
sputum unveiled consolidation in right upper 
lobe (RUL) in chest x-ray. He received a ten-day 
antibiotic course which led to clinical and im-
aging improvement. Nonetheless, symptoms as 
well as radiographic findings reappeared three 
months later. Chest Computed Tomography (CT) 
demonstrated infiltration in the RUL (Fig. 1A, B). 
A second chest CT was performed two months 
later showing improvement of infiltrations; yet, 
a suspicious area of pathologic tissue in the right 
upper bronchus (RUB) (Fig. 1C, D).
The patient was completely asymptomatic 
on admission and in excellent physical condition. 
Chest X-ray on admission did not show any pulmo-
nary infiltrates. He underwent fiberoptic bronchos-
copy, which demonstrated a white polypoid mass 
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Figure 1. Chest Computed Tomography (CT) demonstrating infiltration in the right upper lobe (A, B). A second chest CT was performed two months 
later showing improvement of infiltrations; yet, a suspicious area of pathologic tissue in the right upper bronchus (C, D)
Figure 2. Bronchoscopy demonstrating a white polypoid mass almost 
occluding right upper lobe
Figure 3. PET/CT did not reveal any abnormal hypermetabolic activity
almost occluding RUB (Fig. 2). Most of the tumor 
was removed with the use of snare diathermy. 
Histologic examination showed neoplasmatic 
large cells with eosinophilic and clear cytoplasm, 
areas of necrosis and no keratinization. Further 
immunohistochemistry demonstrated Cytokeratin 
8/18 [+], Vimentin [+], Epithelial Membrane An-
tigen (EMA) [+], Thyroid Transcription Factor-1 
(TTF-1) [–], CD10 [-], Cytokeratin 7 [–]. According 
to our pathologists, these features were in favor 
of metastatic Clear-Cell Renal Cell Carcinoma. 
Cultures for bacteria, fungi and Mycobacterium 
tuberculosis were negative.
Follow up with PET/CT four weeks later did 
not reveal any abnormal hypermetabolic activity 
(Fig. 3). Subsequently, Sunitinib, an angiogenesis 
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inhibitor, was prescribed as adjuvant regimen. 
To this end, 12 months later, the patient is stable 
without any recurrence.
Discussion
Lung metastases from extrathoracic malignan-
cies are frequently identified, yet endobronchial 
metastases are very uncommon [1, 2]. Their preva-
lence varies depending on definition criteria [3]. In 
autopsy series, inclusion of only direct metastasis 
in the bronchus itself resulted into a prevalence 
ranging between 2–5% [1, 3]. Nevertheless, prev-
alence was much higher in cases where investiga-
tors defined EBM as invasion of the bronchial wall 
from parenchymal lesions or metastatic lymph 
nodes [2, 3]. EBM may mimic bronchogenic car-
cinoma, rendering its differential diagnosis from 
primary lung carcinoma a challenging task [4].
Most common symptoms are cough, hemop-
tysis, dyspnea and wheezing in the context of 
recurrent pulmonary infections due to local ate-
lectasis [1–5, 7]. In rare cases, patients with EBM 
may be totally asymptomatic [10]. With regards 
to radiographic findings, chest x-ray may reveal 
abnormalities such as solitary or multiple nod-
ules, masses and obstructive atelectasis [1–5, 8]. 
CT is a valuable diagnostic tool demonstrating 
EBM as polypoid, finger glove or bronchial wall 
thickening lesions [9]. Furthermore, findings such 
as nodules, masses, consolidation, peribronchial 
density, atelectasis and hilar or mediastinal lym-
phadenopathy may be present [3, 5, 6].
Bronchial biopsies through bronchoscopy 
represent the gold-standard for disease diagnosis 
[1, 4, 5, 9, 10]. Lesions can be located anywhere in 
the tracheobronchial tree with a predilection for 
the right lung in most of cases [5]. With regards to 
immunohistochemistry of renal cell carcinomas, 
almost all stain positive for CK18, while 14–40% 
are also positive for CK8 [11]. EMA/ MUC1 is 
seen in 77–100% of cases and its overexpression 
is correlated with tumor grade [12]. Immunore-
activity for CK7 and CK19 is less common [11].
Depending on the awareness of the treating 
doctor the mean reported time between initial 
diagnosis of the primary malignancy and the di-
agnosis of EBM ranges between 0 and 112 months 
[3–6, 8]. Reported median survival also ranges 
from 1 to 39 months, depending on the biological 
behavior of the primary tumor and the latency 
time of diagnosis [3, 4, 6, 8].
Treatment approach of EBM should be indi-
vidualized on the basis of histology, biological 
behavior, anatomic location and patient’s perfor-
mance status [4, 10]. Systemic chemotherapy may 
be an option as well external radiation particularly 
in located obstructive lesions [4, 10]. Intervention-
al endoscopic procedures such as electrocoagula-
tion, forceps, cryotherapy, diathermic snares, Nd-
YAG laser, photodynamic therapy can be applied 
as palliative therapeutic strategies [7, 10].
 Conclusion 
Our case report underlines the need for vigi-
lance for early referral of patients with extratho-
racic malignancies and persistent respiratory 
symptoms to a pulmonologist for further evalua-
tion, regardless of radiographic findings. Interven-
tional endoscopic procedures such as snare dia-
thermy may represent fruitful and relatively safe 
therapeutic approaches for EBM presenting with 
small base attachment and especially from renal 
cell carcinoma which are highly vascularized and 
consequently hemorrhagic tumor lesions [13, 14]. 
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